½ÃÀ庸°í¼­
»óǰÄÚµå
1587688

¼¼°èÀÇ ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀå ¿¹Ãø : À¯Çüº°, Á¦Á¦ À¯Çüº°, ±â´É¼ºº°, ¿ëµµº°, Áö¿ªº° ºÐ¼®(-2030³â)

Sophorolipids Market Forecasts to 2030 - Global Analysis By Type (Acidic Sophorolipids and Lactonic Sophorolipids), Formulation Type (Liquid Sophorolipids and Powdered Sophorolipids), Functionality, Application and by Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀåÀº 2024³â¿¡ 5¾ï 3,396¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, ¿¹Ãø ±â°£ µ¿¾È CAGR 7.08%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â 8¾ï 493¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù.

¼ÒÆ÷·Î¸®Çǵå´Â ĵµð´Ù º½ºñÄݶó¿Í °°Àº ƯÁ¤ È¿¸ð Á¾ÀÌ ½Ä¹°¼º ±â¸§°ú ´ç°ú °°Àº Àç»ý °¡´ÉÇÑ ÀÚ¿øÀ» ¹ßÈ¿½ÃÄÑ »ý»êÇÏ´Â ¹ÙÀÌ¿À ¼­ÆÑÅÏÆ®ÀÇ ÀÏÁ¾ÀÔ´Ï´Ù. ÀÌ ¹«µ¶¼º »ýºÐÇØ¼º ¹°ÁúÀº ÀǾàǰ, ¼¼Á¦, È­Àåǰ, ³ó¾÷ µî ´Ù¾çÇÑ ºÎ¹®¿¡¼­ ÀÌ¿ëµÇ°í ÀÖÀ¸¸ç, ģȯ°æÀûÀΠƯ¼ºÀÌ ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. ¼ÒÆ÷·Î¸®Çǵå´Â Ç¥¸é Àå·ÂÀ» ÀúÇϽÃŰ´Â ´É·ÂÀÌ Àß ¾Ë·ÁÁ® Àֱ⠶§¹®¿¡ Á¦Á¦ÀÇ ¾ÈÁ¤Á¦, ¼¼Á¤Á¦, À¯È­Á¦·Î¼­ À¯¿ëÇÕ´Ï´Ù.

BIoTechnology Advances ÀâÁö¿¡ °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é ¼ÒÆ÷·Î¸®Çǵå´Â µ¶¼ºÀÌ ³·°í »ýºÐÇØ¼ºÀÌ ³ô°í È¿°úÀûÀÎ °è¸éȰ¼º Ư¼ºÀ» °®±â ¶§¹®¿¡ °¡Àå À¯¸ÁÇÑ ¹ÙÀÌ¿À°è¸éȰ¼ºÁ¦ Áß ÇϳªÀÔ´Ï´Ù. ÀÌ ¿¬±¸¿¡¼­´Â ¶ÇÇÑ ¼ÒÆ÷·Î¸®Çǵå´Â Ç¥¸é Àå·ÂÀ» 33mN/m±îÁö ÀúÇϽÃų ¼ö Àֱ⠶§¹®¿¡ ¼¼Á¦³ª ÆÛ½º³ÎÄɾî Á¦Ç° µî ´Ù¾çÇÑ ¿ëµµ¿¡ ¸Å¿ì È¿°úÀûÀÓÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ģȯ°æ Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½É Áõ°¡

¼ÒºñÀÚÀÇ È¯°æ¹®Á¦¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í, ÇÕ¼ºÈ­ÇÐÁ¦Ç°ÀÌ »ýŰ質 Àΰ£ÀÇ °Ç°­¿¡ ÁÖ´Â ÇØ¿¡ ÀÇÇØ ģȯ°æ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¼ÒÆ÷·Î¸®Çǵå´Â µ¶¼ºÀÌ ¾ø°í »ýºÐÇØ¼ºÀÌ ÀÖÀ¸¸ç Àç»ý °¡´ÉÇÑ ÀÚ¿ø¿¡¼­ À¯·¡Çϱ⠶§¹®¿¡ ±âÁ¸ÀÇ °è¸éȰ¼ºÁ¦ÀÇ ´ëüǰÀ¸·Î ¸Å·ÂÀûÀÔ´Ï´Ù. ¶ÇÇÑ, õ¿¬ ¼ººÐÀ» ¿ä±¸ÇÏ´Â ¼ÒºñÀÚÀÇ ¼±È£µµ¸¦ ÃæÁ·½Ã۱â À§ÇØ Á¦Ç° °³¼±¿¡ Àû±ØÀûÀ¸·Î ³ë·ÂÇϰí ÀÖ´Â °³ÀÎ °ü¸® ¹× °¡Á¤¿ë ¼¼Á¤ »ê¾÷¿¡¼­´Â Áö¼Ó°¡´É¼ºÀ¸·ÎÀÇ ÀüȯÀÌ Æ¯È÷ µÎµå·¯Áý´Ï´Ù.

³ôÀº Á¦Á¶ ºñ¿ë

¼ÒÆ÷·Î¸®Çǵå´Â º¹ÀâÇÑ ¹ßÈ¿ ÀýÂ÷¿Í Ư¼ö ¿ø·á°¡ ÀÚÁÖ ÇÊ¿äÇϱ⠶§¹®¿¡ ±âÁ¸ÀÇ ÇÕ¼º °è¸éȰ¼ºÁ¦º¸´Ù Á¦Á¶ ºñ¿ëÀÌ ³ô½À´Ï´Ù. ƯÈ÷ ¼ÒºñÀÚ³ª ±â¾÷ÀÌ ºñ¿ë ´ëºñ È¿°ú¸¦ Áß½ÃÇÏ´Â ½ÃÀå¿¡¼­´Â ÀÌ °¡°Ý Â÷ÀÌ¿¡ µû¶óÀÇ ¸Å·ÂÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ,ÀÌ ¹®Á¦´Â ÇÏ·ù ó¸® ¹× Á¤Á¦¿¡ ¼Ò¿äµÇ´Â ³ôÀº ºñ¿ëÀ¸·Î ´õ¿í ¾ÇÈ­µÇ¾î ¼ÒÆ÷·Î¸®Çǵ尡 À¯¸íÇÑ È­ÇÐ °è¸é Ȱ¼ºÁ¦¿Í °¡°ÝÀ¸·Î °æÀïÇϱⰡ ¾î·Æ½À´Ï´Ù.

Á¦¾à ¹× ÀÇ·á »ê¾÷¿¡¼­ÀÇ ¼ºÀå

¾à¹°Àü´Þ ½Ã½ºÅÛ ¹× ÀÇ·á ¿ëµµ¿¡¼­ ¼ÒÆ÷·Î¸®ÇǵåÀÇ »ç¿ë È®´ë°¡ ÀÇ·á ÀǾàǰ ºÎ¹®ÀÇ Å« ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. Àúµ¶¼º, »ýüÀûÇÕ¼º, Ç×±Õ¼º µîÀÇ Æ¯Áú·Î ÀÇ·á±â±â ÄÚÆÃÀ̳ª »óó Äɾî Á¦Ç° µî ´Ù¾çÇÑ Á¦¾à Á¦Á¦¿¡ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ »ê¾÷ÀÇ ¼ºÀåÀº Á¦Á¶¾÷ü¿¡°Ô »õ·Î¿î Á¦Ç°°ú ¿ëµµ¸¦ »ý»êÇϴ dzºÎÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

Àΰø °è¸éȰ¼ºÁ¦¿ÍÀÇ °­·ÂÇÑ °æÀï

¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀå¿¡¼­ °¡Àå Å« À§ÇùÀÌ µÇ´Â °ÍÀº ±× Á¤Æò ÀÖ´Â ¼º´É°ú Á¦Á¶ ºñ¿ëÀÌ ³·Àº °ÍÀ¸·Î Á¤Æò ÀÖ´Â ÇÕ¼º °è¸éȰ¼ºÁ¦ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀüÅëÀû °è¸éȰ¼ºÁ¦´Â °ø¾÷ ¿ëµµ, ¼¼Á¦, ÆÛ½º³Î ÄÉ¾î µî ¸¹Àº ºÎ¹®¿¡ Á¤ÂøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àß ¾Ë·ÁÁø ÇÕ¼º ´ëüǰ µî¿¡¼­ ¼ÒÆ÷·Î¸®Çǵå¿Í °°Àº ¹ÙÀÌ¿À ´ëüǰÀ¸·Î ÀÌÇàÇϵµ·Ï »ý»êÀÚ³ª ¼ÒºñÀÚ¸¦ ¼³µæÇÏ´Â °ÍÀº ƯÈ÷ ºñ¿ëÀ̳ª ±â´É¼ºÀÌ ÀÇ»ç °áÁ¤½Ã¿¡ Áß¿äÇÑ °í·Á »çÇ×ÀÌ µÇ´Â °æ¿ì ¾î·Á¿î °úÁ¦ÀÔ´Ï´Ù. ÀÌ ¶§¹®¿¡, ½ÃÀåÀº ´õ Çö´ëÀûÀ̰í ȯ°æ ģȭÀûÀÎ ¼Ö·ç¼ÇÀ» ¹Þ¾ÆµéÀÌ´Â °ÍÀ» ¸Á¼³ÀÔ´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀåÀº COVID-19ÀÇ Å« À¯Çà¿¡ ÀÇÇØ Å« ¿µÇâÀ» ¹Þ¾ÒÁö¸¸, ±× ÁÖ¿ä ¿øÀÎÀº Á¦Á¶ Áö¿¬, °æÁ¦ ºÒÈ®½Ç¼º, ¼¼°è °ø±Þ¸ÁÀÇ È¥¶õÀ̾ú½À´Ï´Ù. ºÏ¹Ì, À¯·´, ¾Æ½Ã¾Æ¿¡¼­ÀÇ Á¶¾÷Á¤Áö³ª ±â¾÷ÀÇ Æó¼â·Î ÀÎÇØ »ý»ê ´É·ÂÀÌ ¹æÇصǾú°í ÀÌ·¯ÇÑ ¹ÙÀÌ¿À °è¸é Ȱ¼ºÁ¦°ø±ÞÀÌ °¨¼ÒÇß½À´Ï´Ù. ÆÒµ¥¹ÍÀÇ À¯Çà¿¡ ÀÇÇØ Áö¼Ó°¡´É¼º°ú À§»ý¸éÀÌ Áß½ÃµÇ°Ô µÇ¾úÀ½¿¡µµ ºÒ±¸Çϰí, »ê¾÷ Àüü°¡ ½ÅÁßÇÑ ÁöÃâÀ» ½Ç½ÃÇ߱⠶§¹®¿¡ ½ÃÀå ÀüüÀÇ ¼ºÀåÀº ¾ïÁ¦µÇ¾ú½À´Ï´Ù. ±×·¯³ª »ê¾÷ÀÌ Á¡Â÷ Á¶¾÷À» Àç°³Çϰí, ƯÈ÷ ÀǾàǰÀ̳ª ÆÛ½º³ÎÄÉ¾î µîÀÇ »ê¾÷¿¡¼­ °ø±Þ Á¦¾àÀÌ ¿ÏÈ­µÇ±â ½ÃÀÛÇϸé, ¼ÒÆ÷·Î¸®Çǵ忡 ´ëÇÑ »õ·Î¿î ¿ä±¸°¡ ž½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È »ê¼º ¼ÒÆ÷·Î¸®ÇÇµå ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ Àü¸Á

¸¹Àº ¿ëµµ¿Í À¯¸®ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ »ê¼º ¼ÒÆ÷·Î¸®ÇÇµå ºÎ¹®ÀÌ ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¸î¸î È¿¸ðÁ¾, ƯÈ÷ Starmerella bombicolaÀÇ ¹ßÈ¿¿¡ ÀÇÇØ »ê¼º ¼ÒÆ÷·Î¸®Çǵ尡 »ý¼ºµÇÁö¸¸, À̵éÀº ¾çÄ£¸Å¼ºÀÎ °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç, ±× ¶§¹®¿¡ È¿À²ÀûÀÎ °è¸éȰ¼ºÁ¦°¡ µË´Ï´Ù. »ê¼º¼ÒȦ·Î¸®Çǵå´Â ¼ö¿ë¼ºÀÌ ³ô°í °­·ÂÇÑ ±âÆ÷¼ºÀ» °¡Áö°í ÀÖ¾î ¹ÙÀ̿÷¹¸Þµð¿¡ ¶ÇÇÑ, À¯Á¦Ç°, È­Àåǰ µî ´Ù¾çÇÑ ¿ëµµ¿¡ ÀûÇÕÇÕ´Ï´Ù. ¶ÇÇÑ, ÇÕ¼º °è¸éȰ¼ºÁ¦¿¡ ºñÇØ »ýºÐÇØ¼ºÀÌ ³ô°í, µ¶¼ºµµ ³·±â ¶§¹®¿¡ ƯÈ÷ ȯ°æ ģȭÀûÀ̰í Áö¼Ó °¡´ÉÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ±âÈ£°¡ º¯È­ÇÔ¿¡ µû¶ó, ±× ¸Å·ÂÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

½ºÅ² ÄÁµð¼Å´× ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀÌ ¿¹»óµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È, ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀåÀÇ ½ºÅ² ÄÁµð¼Å´×Á¦ ºÎ¹®Àº °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÆÛ½º³ÎÄɾî Á¦Ç°, ƯÈ÷ ½ºÅ² Äɾî Á¦Çü¿¡¼­ ¾ÈÀüÇϰí È¿À²ÀûÀÎ ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀÌ·¯ÇÑ È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ÇǺο¡ ºÎµå·´°Ô º¸½À¼ºÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁø ¼ÒÆ÷·Î¸®Çǵå´Â ÇǺο¡ ºÎ´ãÀ» ÁÖÁö ¾Ê°í Á¦Ç°ÀÇ ¼º´ÉÀ» Çâ»ó½ÃŰ´Â ¶Ù¾î³­ ½ºÅ² ÄÁµð¼Å´×Á¦ÀÔ´Ï´Ù. ¶ÇÇÑ º¸½À·ÂÀ» ³ôÀÌ°í ºÎµå·¯¿î ÅØ½ºÃ³¸¦ Á¦°øÇÏ´Â ´É·ÂÀÌ Àֱ⠶§¹®¿¡ ·Î¼Ç, Å©¸² ¹× ±âŸ È­Àåǰ ¿ëµµ ºÐ¾ß¿¡¼­ ³ôÀº Àα⸦ ÀÚ¶ûÇÕ´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» °¡Áø Áö¿ª

¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀåÀº À¯·´ÀÌ Áö¹èÀûÀÔ´Ï´Ù. ¾ö°ÝÇÑ È¯°æ¹ý°ú ¼ÒºñÀÚ¿Í Á¦Á¶¾÷ü ¸ðµÎ¿¡ ÀÇÇÑ Áö¼Ó °¡´ÉÇÑ ½Çõ¿¡ ´ëÇÑ °­ÇÑ °íÁýÀÌ ÀÌ ¿ìÀ§¼ºÀÇ ÁÖ¿ä ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. À¯·´ÀÌ ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀåÀ» ¼±µµÇÏ´Â ÀÌÀ¯´Â ¼®À¯È­ÇÐÁ¦Ç°¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß´Â µ¥ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç ģȯ°æ ´ëüǰ¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀǽÄÀÌ ³ô¾ÆÁö±â ¶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ Á¦Ç°°³¹ßÀÇ Áøº¸¿Í ÆÛ½º³ÎÄɾî, ³ó¾÷, ÀǾàǰ µî ¸¹Àº »ê¾÷¿¡¼­ÀÇ ¿ëµµ È®´ë·Î Áö¼Ó°¡´É¼ºÀÌ ÃÖ¿ì¼±»çÇ×À¸·Î Áö¼ÓµÇ±â ¶§¹®¿¡ À¯·´ ½ÃÀåÀº ´õ¿í ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª

¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀåÀº ±Þ¼ÓÇÑ »ê¾÷È­¿Í Áö¼Ó °¡´ÉÇÑ ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹ÙÀÌ¿À ±â¹Ý °è¸éȰ¼ºÁ¦°¡ È­Àåǰ, ÀǾàǰ, ³ó¾÷¿¡¼­ Á¡Á¡ »ç¿ëµÇ¸é¼­ Áß±¹°ú Àεµ¿Í °°Àº ±¹°¡°¡ ÀÌ È®ÀåÀ» À̲ø°í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ¿Í ±â¾÷ ¸ðµÎ ±âÁ¸ÀÇ È­Çаè¸éȰ¼ºÁ¦¸¦ ´ëüÇϴ ȯ°æ ģȭÀûÀÎ °ÍÀ» ã°í Àֱ⠶§¹®¿¡ ÀÌ Áö¿ªÀÇ ±×¸° ±â¼ú°ú ȯ°æ ÀǽĿ¡ ´ëÇÑ °æµµ¿¡ ÀÇÇØ ¼ÒÆ÷·Î¸®ÇÇµå ¼ö¿ä´Â ÇÑÃþ ´õ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹ÙÀÌ¿À º£À̽º Á¦Ç°À» Áö¿øÇÏ´Â Á¤ºÎ ÇÁ·Î±×·¥µµ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¾ÕÀ¸·Î ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ±â¾÷ÀÌ µÉ °ÍÀ¸·Î ÀÚ¸®Àâ°í ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃã ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ÁøÃâ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå ÃßÁ¤, ¿¹Ãø ¹× CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞº° ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç Á¤º¸¿ø
    • 1Â÷ Á¶»ç Á¤º¸¿ø
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼­¹®
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀå : À¯Çüº°

  • ¼­¹®
  • »ê¼º ¼ÒÆ÷·Î¸®Çǵå
  • ¶ôÅæ ¼ÒÆ÷·Î¸®Çǵå

Á¦6Àå ¼¼°èÀÇ ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀå : Á¦Á¦ À¯Çüº°

  • ¼­¹®
  • ¾×ü ¼ÒÆ÷·Î¸®Çǵå
  • ºÐ¸» ¼ÒÆ÷·Î¸®Çǵå

Á¦7Àå ¼¼°èÀÇ ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀå : ±â´É¼ºº°

  • ¼­¹®
  • °è¸éȰ¼ºÁ¦
  • À¯È­Á¦
  • ¹ßÆ÷Á¦
  • ½ºÅ² ÄÁµð¼Å´×Á¦

Á¦8Àå ¼¼°èÀÇ ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀå : ¿ëµµº°

  • ¼­¹®
  • °¡Á¤¿ë ¼¼Á¦
  • ÆÛ½º³ÎÄÉ¾î ¹× È­Àåǰ
  • ³ó¾÷±â¾÷
  • ½Äǰ÷°¡¹°
  • »ê¾÷¿ë ¹× ¾÷¹«¿ë Ŭ¸®³Ê
  • À¯ÀüÈ­Çоàǰ
  • ¼¶À¯
  • ÀǾàǰ°ú ÀÇ·á
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¼ÒÆ÷·Î¸®ÇÇµå ½ÃÀå : Áö¿ªº°

  • ¼­¹®
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä °³¹ß

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷ ¹× ÇÕÀÛÅõÀÚ(JV)
  • Àμö ¹× ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • BASF SE
  • Evonik Industries AG
  • Unilever
  • Holiferm Limited
  • Allied Carbon Solutions Co., Ltd.
  • Givaudan SA
  • Ferro Corporation
  • Biobar Pty Ltd.
  • Tokyo Chemical Industry
  • Syngenta AG
  • Koninklijke DSM NV
  • Saraya Co. Ltd
  • Dow Inc.
  • Mg Intobio Co Ltd
  • Soliance
  • Henkel AG & Co. KGaA
  • Sabic
  • Kaneka Corporation
AJY 24.11.22

According to Stratistics MRC, the Global Sophorolipids Market is accounted for $533.96 million in 2024 and is expected to reach $804.93 million by 2030 growing at a CAGR of 7.08% during the forecast period. Sophorolipids are a type of biosurfactant produced by certain yeast species, such as Candida bombicola, through the fermentation of renewable resources like vegetable oils and sugars. These non-toxic, biodegradable substances are utilized in a variety of sectors, such as pharmaceuticals, detergents, cosmetics, and agriculture, and have drawn notice for their eco-friendly qualities. Because of their well-known capacity to lower surface tension, sophorolipids are useful stabilizers, detergents, and emulsifiers in formulations.

According to a study published in the journal Biotechnology Advances, sophorolipids are among the most promising biosurfactants due to their low toxicity, high biodegradability, and effective surface-active properties. The study also highlights that sophorolipids can reduce surface tension to as low as 33 mN/m, making them highly effective in various applications such as detergents and personal care products.

Market Dynamics:

Driver:

Growing consumer interest in eco-friendly products

The demand for eco-friendly products is being driven by consumers growing awareness of environmental issues and the harm that synthetic chemicals cause to ecosystems and human health. Sophorolipids are appealing substitutes for conventional surfactants because they are non-toxic, biodegradable, and derived from renewable resources. Additionally, in the personal care and household cleaning industries, where companies are actively working to reformulate products to satisfy consumer preferences for natural ingredients, this shift towards sustainability is especially noticeable.

Restraint:

High costs of production

Sophorolipids are more expensive to produce than traditional synthetic surfactants because they frequently require intricate fermentation procedures and specialized raw materials. Their appeal may be limited by this price difference, particularly in markets where consumers and businesses place a high value on cost-effectiveness. Furthermore, this problem is made even worse by the high expenses of downstream processing and purification, which make it challenging for sophorolipids to compete on price with well-known chemical surfactants.

Opportunity:

Growth in the pharmaceutical and healthcare industries

The growing use of sophorolipids in drug delivery systems and medical applications is anticipated to drive significant growth in the healthcare and pharmaceuticals segment. Because of their low toxicity, biocompatibility, and antimicrobial qualities, they can be used in a variety of pharmaceutical formulations, such as medical device coatings and wound care products. Moreover, the growth of this industry presents manufacturers with rich chances to create new products and applications.

Threat:

Strong competition from artificial surfactants

Due to their well-established performance and lower production costs, established synthetic surfactants pose the biggest threat to the sophorolipids market. These traditional surfactants are well-established in a number of sectors, such as industrial applications, detergents, and personal care. Additionally, convincing producers and consumers to move from well-known synthetic alternatives to bio-based substitutes like sophorolipids is a difficult task, particularly when cost and functionality are important considerations when making decisions. Because of this, the market is hesitant to embrace more modern, environmentally friendly solutions.

Covid-19 Impact:

The market for sophorolipids was greatly impacted by the COVID-19 pandemic, mostly due to delays in manufacturing, economic uncertainty, and disruptions in global supply chains. Production capacity was hampered by lockdowns and company closures in North America, Europe, and Asia, which reduced the supply of these bio-based surfactants. Overall market growth was constrained by cautious spending across industries, despite the pandemic's increased emphasis on sustainability and hygiene. However, a renewed need for sophorolipids arose as industries gradually resumed operations and supply constraints started to lessen, especially in industries like pharmaceuticals and personal care.

The Acidic Sophorolipids segment is expected to be the largest during the forecast period

Due to its many uses and advantageous characteristics, the acidic sophorolipid segment dominates the sophorolipids market. The fermentation of several yeast species, most notably Starmerella bombicola, yields acidic sophorolipids, which are known for being amphiphilic and thus making them efficient surfactants. Because of their greater water solubility and potent foaming properties, acidic sophorolipids are appropriate for a variety of applications, such as bioremediation, dairy, and cosmetics. Moreover, their increased biodegradability and decreased toxicity in comparison to synthetic surfactants add to their allure, especially as consumer preferences for environmentally friendly and sustainable products change.

The Skin Conditioning Agents segment is expected to have the highest CAGR during the forecast period

Over the course of the forecast period, the sophorolipids market's skin conditioning agents segment is anticipated to grow at the highest CAGR. The rising demand for safe and efficient ingredients in personal care products, especially skincare formulas, is the main driver of this expansion. Well-known for their skin-friendly and moisturizing qualities, sophorolipids are great skin conditioning agents that improve product performance without being harsh on the skin. Additionally, they are highly sought after in lotions, creams, and other cosmetic applications because of their capacity to enhance hydration and offer a smooth texture.

Region with largest share:

The market for sophorolipids is dominated by the European region. Strict environmental laws and a strong emphasis on sustainable practices by both consumers and manufacturers are the main drivers of this dominance. Europe is positioned as a leader in the sophorolipids market due to the region's dedication to lowering dependency on petrochemical-based products and growing consumer awareness of environmentally friendly alternatives. Furthermore, the European market is anticipated to grow even more as sustainability remains a top priority, propelled by advancements in product development and expanding applications in a number of industries, such as personal care, agriculture, and pharmaceuticals.

Region with highest CAGR:

The market for sophorolipids is expected to grow at the highest CAGR in the Asia-Pacific region due to rapid industrialization and a growing focus on sustainable solutions. As bio-based surfactants are increasingly used in cosmetics, pharmaceuticals, and agriculture, nations like China and India are leading the way in this expansion. The demand for sophorolipids is further increased by the region's dedication to green technologies and environmental awareness, as both consumers and businesses look for environmentally friendly substitutes for conventional chemical surfactants. Moreover, government programs supporting bio-based products are also anticipated to support market growth, positioning Asia-Pacific as a major player in the sophorolipids market going forward.

Key players in the market

Some of the key players in Sophorolipids market include BASF SE, Evonik Industries AG, Unilever, Holiferm Limited, Allied Carbon Solutions Co., Ltd., Givaudan SA, Ferro Corporation, Biobar Pty Ltd., Tokyo Chemical Industry, Syngenta AG, Koninklijke DSM N.V., Saraya Co. Ltd, Dow Inc., Mg Intobio Co Ltd, Soliance, Henkel AG & Co. KGaA, Sabic and Kaneka Corporation.

Key Developments:

In July 2024, BASF and ENGIE signed a 7-year Biomethane Purchase Agreement (BPA). Under the BPA, ENGIE will supply BASF with 2.7 to 3.0 terawatt hours of biomethane throughout the term of the agreement. BASF uses certified biomethane at its Ludwigshafen/Germany and Antwerp/Belgium sites as a sustainable alternative to fossil raw materials in its manufacturing process.

In May 2023, Dow and New Energy Blueopens announced a long-term supply agreement in North America in which New Energy Blue will create bio-based ethylene from renewable agricultural residues. Dow expects to purchase this bio-based ethylene, reducing carbon emissions from plastic production, and using it in recyclable applications across transportation, footwear, and packaging.

In January 2023, Holiferm Limited and Sasol Chemicals, a business unit of Sasol Ltd., announced collaboration to produce and market rhamnolipids and mannosylerythritol lipids (MELs). This collaboration expands the partnership announced in March 2022 between the two companies to develop and commercialise another biosurfactant product, sophorolipids.

Types Covered:

  • Acidic Sophorolipids
  • Lactonic Sophorolipids

Formulation Types Covered:

  • Liquid Sophorolipids
  • Powdered Sophorolipids

Functionalities Covered:

  • Surfactants
  • Emulsifiers
  • Foaming Agents
  • Skin Conditioning Agents

Applications Covered:

  • Household Detergents
  • Personal Care & Cosmetics
  • Agricultural Enterprises
  • Food Additives
  • Industrial & Institutional Cleaners
  • Oilfield Chemicals
  • Textiles
  • Pharmaceutical and Healthcare
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Sophorolipids Market, By Type

  • 5.1 Introduction
  • 5.2 Acidic Sophorolipids
  • 5.3 Lactonic Sophorolipids

6 Global Sophorolipids Market, By Formulation Type

  • 6.1 Introduction
  • 6.2 Liquid Sophorolipids
  • 6.3 Powdered Sophorolipids

7 Global Sophorolipids Market, By Functionality

  • 7.1 Introduction
  • 7.2 Surfactants
  • 7.3 Emulsifiers
  • 7.4 Foaming Agents
  • 7.5 Skin Conditioning Agents

8 Global Sophorolipids Market, By Application

  • 8.1 Introduction
  • 8.2 Household Detergents
  • 8.3 Personal Care & Cosmetics
  • 8.4 Agricultural Enterprises
  • 8.5 Food Additives
  • 8.6 Industrial & Institutional Cleaners
  • 8.7 Oilfield Chemicals
  • 8.8 Textiles
  • 8.9 Pharmaceutical and Healthcare
  • 8.10 Other Applications

9 Global Sophorolipids Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 BASF SE
  • 11.2 Evonik Industries AG
  • 11.3 Unilever
  • 11.4 Holiferm Limited
  • 11.5 Allied Carbon Solutions Co., Ltd.
  • 11.6 Givaudan SA
  • 11.7 Ferro Corporation
  • 11.8 Biobar Pty Ltd.
  • 11.9 Tokyo Chemical Industry
  • 11.10 Syngenta AG
  • 11.11 Koninklijke DSM N.V.
  • 11.12 Saraya Co. Ltd
  • 11.13 Dow Inc.
  • 11.14 Mg Intobio Co Ltd
  • 11.15 Soliance
  • 11.16 Henkel AG & Co. KGaA
  • 11.17 Sabic
  • 11.18 Kaneka Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦